Saxo Equity World Cup: Colombia flops as Denmark rises to the top

Peter Garnry

Head of Equity Strategy, Saxo Bank Group
Peter Garnry joined Saxo in 2010 and is Head of Equity Strategy. In 2016, he became responsible for the quantitative strategies team, which focuses on how to apply computer models to financial markets. He develops trading strategies and analyses of the equity markets as well as individual company stocks applying statistics and models.

For a complete list of five-year price charts for all stocks in Saxo's 2018 Equity World Cup, click here.

The 2018 FIFA World Cup is powering on and so is our Saxo Equity World Cup. After 23 matches (see results below) we are now beginning to see a picture emerging. Most matches in our game have been a good reverse indicator of the winning team in the real World Cup.

The tables below show the groups in our game as of yesterday's matches. The clear trend is that emerging market countries/stocks have done the best except for one standout developed market – Denmark (represented by Novo Nordisk) – which is up 5.2% in USD terms as the Danish company yesterday announced good data on its oral diabetes drug semaglutide, showing promising results on weight reduction compared to Merck’s product Januvia.

In our introduction we highlighted Colombia (Ecopetrol) as a potential winner based on strong price momentum in the days before the tournament, but interestingly enough Ecopetrol is the worst performer since 13 June in USD terms and is down 8.3% as EM equities have been sold off broadly and are also affected by worries over oil prices in a trade war escalation scenario. Our expectation for oil prices is mildly positive over the coming two weeks. Based on current performance (“stock fitness”) Denmark looks to have good chances of go far in the tournament. We will give updates again next week.

Access both platforms from your single Saxo account.

Disclaimer

Any opinions, news, research, analyses, prices or other information contained on this website is provided as general market commentary and does not constitute investment advice or a personal recommendation and does not take into consideration your objectives, financial situation and needs. Saxo Capital Markets UK Limited will not accept liability for any loss or damage including, without limitation, to any loss of profit which may arise directly or indirectly from use of or reliance on such information. We assume no liability for errors, inaccuracies or omissions contained within these materials.

It is important that you understand that with investments, your capital is at risk. We offer leveraged products which carry risk and can result in losses that exceed deposits. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more here.

Additional Key Information Documents are available in our trading platform.

Saxo Capital Markets UK is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871

Please read our full disclaimer - https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer